Antibody drug conjugates market Industry Analysis and Opportunity and Forecast To 2029
The factors such as rising prevalence of cancer related disorders worldwide and emerging markets across the globe are expected to accelerate the market growth in the forecast period of 2022 to 2029. Furthermore, the increased research and clinical trials and growing cases of breast cancer in female will further carve the way for the growth of the market. However, the stringent FDA guidelines for the drug approval of new drug is projected to restraint the market growth rate. On the other hand, the adverse effect after the treatment in some cases also hampers the overall growth of the market.
Comments
Post a Comment